Avista Healthcare Public Acquisition (AHPAU)Prices 30M Units IPO for Proceeds of $300M
Get inside Wall Street with StreetInsider Premium. Claim your 2-week free trial here.
Avista Healthcare Public Acquisition Corp. (Nasdaq: AHPAU), a blank check company formed for the purpose of entering into a merger, share exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses, announced the pricing of its initial public offering of 30,000,000 units at a price of $10.00 per unit. The units will be listed on the NASDAQ Capital Market and trade under the ticker symbol "AHPAU" beginning October 11, 2016. Each unit consists of one Class A ordinary share and one warrant to purchase one-half of one Class A common share. Two warrants may be exercised for one whole Class A ordinary share at a price of $11.50 per share. Once the securities comprising the units begin separate trading, the Class A ordinary shares and warrants are expected to be listed on the NASDAQ Capital Market under the symbols "AHPA" and "AHPAW," respectively.
Credit Suisse is serving as the sole book-running manager for the offering. The Company has granted the underwriters a 45-day option to purchase up to an additional 4,500,000 units at the initial public offering price to cover over-allotments, if any.
The offering is being made only by means of a prospectus. When available, copies of the prospectus may be obtained from Credit Suisse, Prospectus Department, One Madison Avenue, New York, NY 10010; Telephone: (800) 221-1037; email: email@example.com.
A registration statement relating to the securities was declared effective by the SEC on October 7, 2016. This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ra Pharmaceuticals (RARX) Prices Larger Common Stock IPO at $13/Share, in Middle of Expected Range
- Helios and Matheson (HMNY) Enters Zone Loan Amendment; Moves to Lower Conversion Price on Conv. Notes
- Collegium Pharma (COLL) Announces Common Stock Offering
Create E-mail Alert Related CategoriesCorporate News, Hot Corp. News, IPOs
Related EntitiesCredit Suisse, Definitive Agreement, IPO
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!